🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, randomized, double-blind, placebo-controlled, parallel-...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01225393
Treatments Being Tested
A study to evaluate the safety and efficacy of adalimumab in Chinese subjec...
Status
Completed
Location
Site Reference ID/Investigator# 72888
Start Date
2012-08
Trial ID
NCT01646073
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of vedoliz...
Status
Completed
Location
IMC - Diagnostic and Medical Clinic
Start Date
2015-06-29
Trial ID
NCT02497469
Treatments Being Tested
The objectives were: (1) To demonstrate the efficacy of adalimumab in the l...
Status
Completed
Location
Gastroenterology Associates of the East Bay
Start Date
2002-08
Trial ID
NCT01070303
Treatments Being Tested
The purpose of this study is to determine if adalimumab is an effective for...
Status
Completed
Location
Virginia Clinical Research, Inc.
Start Date
2006-09
Trial ID
NCT00274352
Treatments Being Tested
This study seeks to evaluate the safety and efficacy of brazikumab versus p...
Status
Terminated
Location
Research Site
Start Date
2018-12-07
Trial ID
NCT03759288
Treatments Being Tested
The purpose of the study is to assess the safety and efficacy of adalimumab...
Status
Completed
Location
Multiple Locations
Start Date
2003-07
Trial ID
NCT00235859
Treatments Being Tested
This is a study to demonstrate the clinical efficacy and safety of the nano...
Status
Completed
Location
Clinical Site
Start Date
2022-12-13
Trial ID
NCT05640245
Treatments Being Tested
This healthy volunteers study will evaluate 210 subjects who will receive a...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-05
Trial ID
NCT01870986
Treatments Being Tested
To demonstrate the efficacy of 80 mg adalimumab monthly dosing compared wit...
Status
Completed
Location
Multiple Locations
Start Date
2007-12
Trial ID
NCT00647270
Treatments Being Tested